Open house drug discount contracts for the active ingredient Eptinezumab, ATC …

This tender is an 'Open House' procedure initiated by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse (AOK Rhineland-Palatinate/Saarland - The Health Insurance Fund). It seeks to establish drug discount contracts for pharmaceuticals containing the active ingredient Eptinezumab, with the specific ATC code to be detailed in the full tender documents. The 'Open House' model allows for continuous submission of offers from eligible suppliers, aiming to secure cost-effective agreements for the health insurance fund. The focus is on obtaining competitive pricing and ensuring a consistent supply of Eptinezumab-based medications. Suppliers interested in participating must consult the complete tender documentation from AOK Rheinland-Pfalz/Saarland for detailed specifications, quality standards, and contractual obligations. The service.bund.de platform serves only as a notification channel.

This is a supplies contract in the health and medical services, information and communication technology and finance and banking sectors, with a focus on Pharmaceuticals, Health Financing and Insurance. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before February 29, 2028.

Published through service.bund.de (Germany), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.